Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Standard Biotools (LAB) Total Debt (2021 - 2024)

Standard Biotools has reported Total Debt over the past 7 years, most recently at $54.9 million for Q3 2024.

  • Quarterly Total Debt rose 471.12% to $54.9 million in Q3 2024 from the year-ago period, while the trailing twelve-month figure was $54.9 million through Sep 2024, up 471.12% year-over-year, with the annual reading at $57.9 million for FY2023, 607.15% up from the prior year.
  • Total Debt was $54.9 million for Q3 2024 at Standard Biotools, roughly flat from $54.8 million in the prior quarter.
  • Over five years, Total Debt peaked at $57.9 million in Q4 2023 and troughed at $8.2 million in Q4 2022.
  • The 4-year median for Total Debt is $10.2 million (2022), against an average of $21.4 million.
  • Year-over-year, Total Debt decreased 18.46% in 2022 and then soared 607.15% in 2023.
  • A 4-year view of Total Debt shows it stood at $10.0 million in 2021, then fell by 18.46% to $8.2 million in 2022, then soared by 607.15% to $57.9 million in 2023, then decreased by 5.23% to $54.9 million in 2024.
  • Per Business Quant, the three most recent readings for LAB's Total Debt are $54.9 million (Q3 2024), $54.8 million (Q2 2024), and $57.9 million (Q4 2023).